|
Field Trip Background Information
National
Biodiversity Institute (INBio)
Creating Scientific, Community and Market Value from Biodiversity
Santo Domingo de Heredia, Costa Rica
Wednesday April 17, 2002
|
Field
Trip Background Information
Background
Information: Elena Mateo, Lawrence Pratt (EcoConsulta)
Field Trip Led by: Andrea Borel (US Embassy)
|
This field trip
is to visit projects related to the coffee production cooperative
CoopeCafira. This cooperative is visited to demonstrate the efforts
they have made to be able to comply with the local environmental
legal framework and the changing market requirements with the aim
of improving their environmental performance while also maintaining
their competitive position.
Program:
| 9.00 |
Departure
from hotel |
| 9:30 |
Arrival
at INBioParque |
| 10.00 -12:15
|
Visit of
INBioparque and Bioprospecting Program |
| 12.15 |
Lunch,
buffet-style at the Heliconias Restaurant |
| 13.15 |
Departure
to Braulio Carrillo National Park |
| 14.00 |
Arrival
at the Braulio Carrillo National Park, Quebrada Gonzales Biological
Station. Guided tour and talk by Mr. Ricardo Valerio, Director
of Conservation Area. |
| 16.00 |
Departure
to Hotel Real Inter-Continental |
Climate
The climate
of Santo Domingo is essentially the same as that of San Jose. Expect
high temperatures around 23C (75F). At this time of year, expect
sunshine and a light breeze, however there is always the possibility
of an afternoon shower.
What to Bring
Wear comfortable,
casual clothes (preferably long pants) and comfortable shoes. A
hat for sun (and flying or falling "biodiversity") is
recommended since participants will visit the biological exhibits
on the extensive grounds of InbioParque.
1. Introduction
INBio is a government-created non-profit scientific institution
with a mission to serve the public good. INBio´s mission is
to promote a new awareness of the value of biodiversity, and thereby
achieve its conservation and use to improve the quality of life.
It promotes the wise management and use of Costa Rica's biotic wealth
through the development and distribution of information on species,
genes and ecosystems. INBio generates knowledge about biodiversity.
It communicates and promotes this information in many formats designed
to be responsive to a broad spectrum of national and international
users. INBio´s activities support the spiritual, social and
economic development of Costa Rican society in equilibrium with
the environment. INBio´s mission is carried out through:
· Biodiversity inventory, with emphasis on our national protected
areas
· Search for sustainable uses of biodiversity by any and
all social sectors, and promotion of these uses
· Organization and administration of biodiversity information
· Transfer and dissemination of biodiversity knowledge
INBio's headquarters, and its new exhibition center "INBio
Parque" are located 4km from San Jose in the town of Santo
Domingo de Heredia.
2. Background
on Costa Rican Biodiversity
The tropical zones of the American continent, the Neotropics, contain
more species than other tropical regions of the world and, definitely,
many more species than the Planet's temperate and cold zones. Costa
Rica has been considered one of the most diverse regions and it
is estimated that 6% of all living species are found here, even
though this country comprises only 0.01% of the global territory.
When comparing
Costa Rica with large countries well known for their biological
resources, such as Colombia or Brazil, the countries great concentration
of biodiversity becomes evident. For example, if we consider the
number of species for every 10,000 km2, Costa Rica has 295 tree
species, while Colombia has 35 species and Brazil, 6.
Out of the
500,000 species estimated for the country, more than 87,000 (17.4%)
have been described. Over 79% of these species are arthropods. Plants
comprise another important group, of which some 10,979 (91%) species
have been described. Such data indicate that out of the entire biodiversity
described in the world, approximately 6% belongs to Costa Rica.
At present, 98.8% of vertebrates (excluding fish), close to 90%
of plants and 60% of fish have been described. However, out of the
most diverse group (arthropods), less than 20% of species have been
described. The same goes for other invertebrates, excluding mollusks.
Groups such as fungi, bacteria and virus are almost unknown, since
more than 98% of expected species are yet to be described.
3. National
Biodiversity Program
The country has made enormous progress in this direction. During
the last four decades, the National Parks System has been consolidated
and complemented by other types of protected areas; all together,
these represent 25% of the national territory. The creation of the
Ministry of National Resources, Energy and Mines (MIRENEM) --now
Ministry of Environment and Energy (MINAE), helped integrate all
activities related to the management and conservation of the country's
natural resources. Additionally, the concern that these resources
be managed adequately led to national consensus to form a suitable
structure for this purpose, called the National System of Conservation
Areas (SINAC), SINAC is under the direct responsibility of MINAE,
with support and participation of certain private organizations.
Moreover, Costa
Rica has assumed the task of developing the National Biodiversity
Program, aimed at conserving most of the country's existing biodiversity
through the sustainable and equitable utilization of these resources.
The program works according to the following strategy:
1. saving representative samples of Costa Rica's biodiversity through
the establishment of protected wildlands administered by SINAC --
with support of several conservation NGOs and the National System
of Private Reserves;
2. increasing knowledge about the existing biodiversity, particularly
within the protected areas. This process is carried out by universities,
the National Museum, scientists and the National Biodiversity Institute
(INBio), among others;
3. searching for sustainable and rational uses of such biodiversity.
Participants in this search are institutions such as the Clodomiro
Picado Institute, the Tropical Agronomical Center of Research and
Education (CATIE), INBio and several universities, among others.
NOTE: This
national program is based on the framework defined at the international
level in "The Global Biodiversity Strategy" (WRI, IUCN,
UNEP, 1992) and the June 1992 United Nations Conference on Environment
and Development ("Earth Summit"), celebrated in Rio de
Janeiro, Brazil.
3. Bioprospecting
and Intellectual Property
A primary premise to the mission of INBio is that biodiversity will
be conserved only if the areas protected generate enough intellectual
and economic income to sustain conservation efforts and to offset
revenue foregone from other potential uses. One way to generate
this kind of intellectual and economic income is through bioprospecting.
An express goal of INBio is to use bioprospecting to "generate
income from Costa Rica's conservation areas so as to contribute
to Costa Rica's wildland management costs" as well as to the
country's GNP.
Profiting from
biodiversity resources in this way is conditioned on the Costa Rican
government's assertion of property rights over the resources. Intellectual
property rights for "improved genetic and biochemical resources"
have existed for decades. Ownership interests in unimproved genetic
resources, however traditionally have been understood in the context
of the "common heritage doctrine". The essence of the
common heritage doctrine is that wild species are considered "ownerless,
open-access resources". Bioprospecting involves "wild
resources with commercial potential," placing the collected
specimens somewhere in between an intellectual property rights system
and a property rights system based on the common heritage doctrine.
To accommodate the type of resource valuable bioprospecting, the
Biodiversity Convention affirms a country's national sovereignty
over its biodiversity resources.
The Convention
also asserts, however, that source countries are obliged to facilitate
access to their biodiversity resources, while all countries-owners
of biodiversity resources as well as beneficiaries-are obliged to
share the economic benefits from biodiversity. It is on this basis
that INBio, vested with the authority over Costa Rica's biodiversity-rich
Conservation Areas, has been able to halt what had been a one-way
bioprospecting process, and transform the process into a two-way
commercial exchange, allowing Costa Rica as the source country to
profit from its natural biodiversity resources.
In addition
to profiting from facilitating the commercial transfer of biodiversity
resources in a non-destructive manner, INBio also is able to profit
from the value it can add to a party's bioprospecting efforts. The
National Biodiversity Inventory and the trained INBio staff transform
haphazard bioprospecting into an efficient, organized, and focused
endeavour. This type of arrangement has been captured in contractual
relationships between INBio and parties such as pharmaceutical and
biotechnological companies interested in utilizing Costa Rica's
biodiversity resources. Significantly, INBio is "fully empowered
by the Costa Rican government to enter into contracts and agreements
with national and international institutions and individuals."
4. Model
Commercial Agreements
In September, 1991, INBio and US-based pharmaceutical company Merck,
Sharp and Dohme, Inc. entered into a landmark two-year contractual
relationship anchored on sustainably developing Costa Rica's rich
biodiversity resources through bioprospecting. Under the terms of
the deal, which the parties renewed in 1993 and again in 1996, INBio
provided Merck with "chemical extracts from wild plants, insects,
and micro-organisms" primarily from Costa Rica's conservation
areas. Using these chemical extracts, Merck hoped to develop or
find clues that would lead to developing a new medicine. In exchange,
Merck paid INBio an up-front fee of US$1 million, donated US$135,000
worth of equipment for use in chemical extraction, and sent two
natural products chemists to set up the facilities necessary for
chemical extraction and to train INBio scientists in the extraction
process. In addition, INBio would receive a royalty from any commercially
marketable drug developed from a compound it provided. Although
the percentage of the royalty is confidential, it is widely believed
to be between one and three percent of net sales. Because drug development
usually takes as long as ten to fifteen years and costs between
US$300 to 400 million, the possibility of a royalty obviously is
considered a long-term, prospective benefit of the contract.
INBio and Costa
Rica benefit in several other ways from this contract. One is the
relationship with Merck is non-exclusive in that INBio is permitted
to enter into agreements with other pharmaceutical companies, or
other parties interested in gaining access to Costa Rica's biodiversity.
A second is that ten percent of the up-front fee and fiftly percent
of any royalties go to the Costa Rican government's national park
fund to support conservation efforts. This aspect of the relationship
is significant, because it implies that conservation of the biodiversity
resources is valuable in the market. Contracts that create a demand
for species samples also create collection-related jobs for Costa
Ricans. Although less tangible than the above benefits, this deal
also has generated positive public relations for Merck; in 1993,
the National Wildlife Federation bestowed its Environmental Achievement
Award upon Merck for its work toward sustainable development as
represented by its relationship with INBio.
Capitalizing
on the positive exposure from its relationship with Merck, INBio
has since entered into several contractual relationships with other
companies. The set of criteria used in the Merck agreement is the
same for every new agreement thereafter: access, compensation, transfer
of technology, training, and sustainable uses. If one or more of
these criteria are not met by the company, then the potential research
agreement is not carried out.
Source: Hunter, Christopher J, Sustainable bioprospecting: Using
private contracts and international legal principles and policies
to conserve raw medicinal materials, Boston College Environmental
Affairs Law Review, Newton, Fall 1997.
5. Discussion
Questions and Issues
1. Could the
INBio model of bioprospecting be replicated in other countries?
What are the legal, physical and other barriers and opportunities?
2. Can bioprospecting
agreements and similar mechanisms serve conservation goals in other
developing countries? Is it or could it be a sufficient solution
to conservation issues in other parts of the world?
|